Nauzene
NDC 52389-242, Sodium Citrate, tablet, chewable, from Kobayashi Healthcare International, Inc..
- Product NDC
- 52389-242
- Status
- Listed
- Labeler
- Kobayashi Healthcare International, Inc.
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M001
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52389-242 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRISODIUM CITRATE DIHYDRATE230 mg/1
Pharmacologic classes
Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52389-242-10 | 52389024210 | 1 BLISTER PACK in 1 CARTON (52389-242-10) / 10 TABLET, CHEWABLE in 1 BLISTER PACK |
| 52389-242-42 | 52389024242 | 3 BLISTER PACK in 1 CARTON (52389-242-42) / 14 TABLET, CHEWABLE in 1 BLISTER PACK |
| 52389-242-56 | 52389024256 | 4 BLISTER PACK in 1 CARTON (52389-242-56) / 14 TABLET, CHEWABLE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 52389-242 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52389-242 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52389-242. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.